CTI BioPharma (CTIC), Baxter (BAX) to Present Phase 3 PERSIST-1 Data at ASCO 2015
Tweet Send to a Friend
CTI BioPharma (NASDAQ: CTIC) and Baxter International Inc. (NYSE: BAX) announced that data from the randomized Phase 3 PERSIST-1 trial ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
